Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
Cosenza
C A
CA
Department of Surgery, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Tuso
P J
PJ
Chapman
F A
FA
Middleton
Y D
YD
Cramer
D V
DV
Wu
G D
GD
Makowka
L
L
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011917:Rats, Inbred Lew; D014183:Transplantation, Heterologous / Q000276:immunology; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines